Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform

NCT: NCT07333547 · RECRUITING

NCT IDNCT07333547
StatusRECRUITING
Start Date2026-02-03
Completion2036-01

Brief Summary

The WILLEM Registry is a large-scale, single-group, observational, registry study to collect continuous clinical evidence of Willem in real-world settings. Cardiovascular diseases are a major problem for public health and healthcare systems. Electrocardiograms (ECGs) are simple tests which increase diagnostic performance and early detection of cardiovascular diseases. However, its interpretation is complex, time consuming for cardiology experts, and entails high costs for healthcare systems. Willem allows AI-based automatic interpretation and its performance has been examined in previous clinical trials, but additional clinical evidence is needed for its integration in real-world clinical settings. This study will collect clinical evidence of Willem performance to detect cardiac abnormalities in ECGs from high-risk cardiac patients admitted to cardiovascular units.

Frequently Asked Questions

What is Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform?

Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform is a clinical trial registered under NCT07333547. Current status: RECRUITING.

What is the status of NCT07333547?

The current status of NCT07333547 (Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform) is: RECRUITING.

When did Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform start?

Registry Study for the Evaluation of High-risk Cardiac Patients by WILLEM AI-based ECG Platform started on 2026-02-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.